Total submissions: 3
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Laboratory of Medical Genetics, |
RCV002465446 | SCV002760132 | pathogenic | Intellectual disability, autosomal dominant 50 | 2022-11-29 | criteria provided, single submitter | research | |
Labcorp Genetics |
RCV003574975 | SCV004336795 | pathogenic | not provided | 2024-01-04 | criteria provided, single submitter | clinical testing | This sequence change creates a premature translational stop signal (p.Gln389*) in the NAA15 gene. It is expected to result in an absent or disrupted protein product. Loss-of-function variants in NAA15 are known to be pathogenic (PMID: 28191889, 29656860). This variant is not present in population databases (gnomAD no frequency). This premature translational stop signal has been observed in individual(s) with autism spectrum disorder (PMID: 35982160). ClinVar contains an entry for this variant (Variation ID: 1802607). For these reasons, this variant has been classified as Pathogenic. |
Gene |
RCV003574975 | SCV005328049 | pathogenic | not provided | 2023-12-19 | criteria provided, single submitter | clinical testing | Nonsense variant predicted to result in protein truncation or nonsense mediated decay in a gene for which loss-of-function is a known mechanism of disease; Not observed at significant frequency in large population cohorts (gnomAD); This variant is associated with the following publications: (PMID: 35982160) |